Biography
Dr. Andrew M. Blakely is a Staff Clinician in Surgical Oncology at the National Cancer Institute (NCI), part of the National Institutes of Health in Bethesda, Maryland. He specializes in the surgical treatment of mesothelioma and conducts research into novel surgical and multimodal approaches to this disease at the nation's premier cancer research institution. Dr. Blakely trained in general surgery at Johns Hopkins Hospital and completed his surgical oncology fellowship at the NCI. His position at the NIH allows him to treat mesothelioma patients while simultaneously advancing the research that shapes future treatment protocols, with access to clinical trials that are often available nowhere else.
Education & Training
- Medical Degree — Georgetown University School of Medicine (Medicine)
- Residency — Johns Hopkins Hospital (General Surgery)
- Fellowship — National Cancer Institute (Surgical Oncology)
Specialties & Procedures
Clinical Specialties
- Surgical Oncology
- Mesothelioma Research
Surgical Procedures
Board Certifications
- American Board of Surgery
Research Focus
Mesothelioma surgical treatment at NIH, clinical trials for mesothelioma, and novel surgical approaches to thoracic and peritoneal malignancies.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Can mesothelioma patients be treated at the NIH?
Yes. Dr. Blakely treats mesothelioma patients at the National Cancer Institute in Bethesda, Maryland. The NIH often has clinical trials for mesothelioma that are not available at other institutions. Patients can inquire about eligibility through the NCI's Cancer Information Service.